000 | 01374 a2200385 4500 | ||
---|---|---|---|
005 | 20250513210022.0 | ||
264 | 0 | _c20000606 | |
008 | 200006s 0 0 eng d | ||
022 | _a0906-6705 | ||
024 | 7 |
_a10.1034/j.1600-0625.2000.009002097.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLehmann, B | |
245 | 0 | 0 |
_aConversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents. _h[electronic resource] |
260 |
_bExperimental dermatology _cApr 2000 |
||
300 |
_a97-103 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCholecalciferol _xmetabolism |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxylation _xdrug effects |
650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
650 | 0 | 4 |
_aKetoconazole _xpharmacology |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aNADH, NADPH Oxidoreductases _xantagonists & inhibitors |
650 | 0 | 4 | _aNADPH-Ferrihemoprotein Reductase |
650 | 0 | 4 |
_aSerum Albumin, Bovine _xpharmacology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVitamin D _xanalogs & derivatives |
700 | 1 | _aRudolph, T | |
700 | 1 | _aPietzsch, J | |
700 | 1 | _aMeurer, M | |
773 | 0 |
_tExperimental dermatology _gvol. 9 _gno. 2 _gp. 97-103 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1034/j.1600-0625.2000.009002097.x _zAvailable from publisher's website |
999 |
_c10725484 _d10725484 |